Home › Interstitial Lung Diseases
Pag-aaral pangklinika para sa Interstitial Lung Diseases na nagre-recruit sa U.S.
52 pag-aaral para sa Interstitial Lung Diseases ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY17 pag-aaral
- Philadelphia, PA16 pag-aaral
- Los Angeles, CA14 pag-aaral
- Kansas City, KS13 pag-aaral
- Durham, NC13 pag-aaral
- Houston, TX12 pag-aaral
- Chicago, IL12 pag-aaral
- Charleston, SC11 pag-aaral
- Ann Arbor, MI11 pag-aaral
- Aurora, CO10 pag-aaral
- Boston, MA9 pag-aaral
- Rochester, MN9 pag-aaral
- Salt Lake City, UT9 pag-aaral
- Birmingham, AL8 pag-aaral
- Dallas, TX8 pag-aaral
- San Francisco, CA8 pag-aaral
- Cincinnati, OH7 pag-aaral
- Minneapolis, MN7 pag-aaral
- Phoenix, AZ7 pag-aaral
- Orlando, FL7 pag-aaral
- Washington, DC6 pag-aaral
- Richmond, VA6 pag-aaral
- Winston-Salem, NC6 pag-aaral
- Tampa, FL6 pag-aaral
- Bend, OR6 pag-aaral
- Jacksonville, FL5 pag-aaral
- Naples, FL5 pag-aaral
- Oklahoma City, OK5 pag-aaral
- Cleveland, OH5 pag-aaral
- Indianapolis, IN5 pag-aaral
- Nashville, TN4 pag-aaral
- Greensboro, NC4 pag-aaral
- New Orleans, LA4 pag-aaral
- Davie, FL4 pag-aaral
- Columbus, OH4 pag-aaral
- Albuquerque, NM4 pag-aaral
- Baltimore, MD4 pag-aaral
- St. Louis, MO4 pag-aaral
- Rochester, NY4 pag-aaral
- Gainesville, FL4 pag-aaral
Ayos sa estado
- Alabama8 pag-aaral
- Arizona12 pag-aaral
- California22 pag-aaral
- Colorado12 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia5 pag-aaral
- Florida22 pag-aaral
- Georgia3 pag-aaral
- Illinois12 pag-aaral
- Indiana5 pag-aaral
- Kansas13 pag-aaral
- Kentucky5 pag-aaral
- Louisiana5 pag-aaral
- Maryland5 pag-aaral
- Massachusetts11 pag-aaral
- Michigan16 pag-aaral
- Minnesota13 pag-aaral
- Mississippi3 pag-aaral
- Missouri6 pag-aaral
- New Jersey3 pag-aaral
- New Mexico4 pag-aaral
- New York19 pag-aaral
- North Carolina17 pag-aaral
- Ohio12 pag-aaral
- Oklahoma5 pag-aaral
- Oregon8 pag-aaral
- Pennsylvania19 pag-aaral
- South Carolina12 pag-aaral
- Tennessee6 pag-aaral
- Texas17 pag-aaral
- Utah9 pag-aaral
- Virginia8 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07201922A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06968845Collagen-targeted PET Imaging for Early Interstitial Lung Disease
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05417776Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 21 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01915511FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07540988An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07234032Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06911632A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07805785Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07473700Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07179380Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07613099RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT06328777LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT05798923A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07285655Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07372989Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07673237A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07175038Pulmonary Fibrosis Foundation Community Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05382572A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07323732A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07816185A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05878717A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07333183Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT00258583Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.